PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

USC researchers discover better way to identify DNA variants

2021-07-12
(Press-News.org) USC researchers have achieved a better way to identify elusive DNA variants responsible for genetic changes affecting cell functions and diseases.

Using computational biology tools, scientists at the university's Dornsife College of Letters, Arts and Sciences studied "variable-number tandem repeats" (VNTR) in DNA. VNTRs are stretches of DNA made of a short pattern of nucleotides repeated over and over, like a plaid pattern shirt. Though they comprise but 3% of the human genome, the repetitive DNA governs how some genes are encoded and levels of proteins are produced in a cell, and account for most of the structural variation.

Current methods do not accurately detect the variations in genes in some repetitive sequences. The new method by the USC scientists can detect variants among different populations of people and how it they affect gene expression, which helps to discover links between VNTR variation and traits or disease.

"This type of repetitive DNA has been called 'dark matter' of the human genome because it has been difficult to sequence and analyze how it varies," said Mark Chaisson, assistant professor of quantitative and computational biology and corresponding author of the study. "We showed that variation in dark matter can have a substantial effect on cellular processes, so future studies may use this approach to understand the genetic basis of disease and ways to improve our health."

The study was published in Nature Communications on July 12

The study also says: Variants in genetic codes are responsible for Huntington's disease, Lou Gehrig's disease (ALS), schizophrenia, diabetes and attention-deficit disorder, as previous research has shown. While other tools, based on algorithms, have been developed to detect genetic variants, they provide incomplete information, especially for the VNTRs. The new software tool the USC scientists developed derives from a repeat-pangenome graph, a data structure that encodes population diversity and repetitions of VNTR locations on a chromosome to identify more gene sequences with better accuracy.

INFORMATION:

The study authors are Mark Chaisson and Tsung-Yu Lu at the Department of Quantitative and Computational Biology at USC.

Funding for the study comes from the National Human Genome Research Institute (NHGRI) (grant #U01 HG010973 and #U24 HG007497). Cell lines/DNA samples were obtained from the National Institute for General Medical Sciences' Human Genetic Repository at the New York Genome Center with NHGRI grants #3UM1HG008901-03S1 and #3UM1HG008901-04S2.



ELSE PRESS RELEASES FROM THIS DATE:

Scientists blueprint bacterial enzyme believed to "stealthily" suppress immune response

2021-07-12
Scientists have produced the first fine-detail molecular blueprints of a bacterial enzyme known as Lit, which is suspected to play a "stealthy" role in the progression of infection by reducing the immune response. Blueprints such as these allow drug designers to uncover potential weaknesses in bacterial arsenals as they seek to develop new therapeutics that may help us win the war against antibiotic resistance. The study, led by scientists from the School of Biochemistry and Immunology and the Trinity Biomedical Sciences Institute (TBSI) at Trinity College Dublin, has just been published by leading international journal Nature Communications. Lipoproteins and their role in ...

A Trojan horse could help get drugs past our brain's tough border patrol

2021-07-12
Sclerosis, Parkinson's Disease, Alzheimer's and epilepsy are but a few of the central nervous system disorders. They are also very difficult to treat, since the brain is protected by the blood-brain barrier. The blood-brain barrier works as a border wall between the blood and the brain, allowing just certain molecules to enter the brain. And whereas water and oxygen can get through, as can other substances such as alcohol and coffee. But it does block more than 99 percent of potentially neuroprotective compounds from reaching their targets in the brain. Now, ...

Just 25 mega-cities produce 52% of the world's urban greenhouse gas emissions

2021-07-12
In 2015, 170 countries worldwide adopted the Paris Agreement, with the goal limiting the average global temperature increase to 1.5°C. Following the agreement, many countries and cities proposed targets for greenhouse gas mitigation. However, the UNEP Emissions Gap Report 2020 shows that, without drastic and strict actions to mitigate the climate crisis, we are still heading for a temperature increase of more than 3°C by the end of the 21st century. A new study published in the journal Frontiers in Sustainable Cities presents the first global balance sheet of greenhouse gasses (GHGs) emitted by major cities around the world. The aim was to research and monitor the effectiveness of historical GHG reduction ...

Addressing social needs may help mitigate distress and improve the health of women with cancer

2021-07-12
A new study published by Wiley early online in CANCER, a peer-reviewed journal of the American Cancer Society, has identified unmet social needs in women with gynecologic cancer that could be addressed to improve care for patients and lessen disparities. For example, identifying patients who reported needing help with reading hospital materials resulted in the use of a cancer care navigator who provided patient education and support, facilitating physician-patient communication and adherence to care recommendations. The prospective survey-based ...

Oncotarget: Inhibitory effects of Tomivosertib in acute myeloid leukemia

Oncotarget: Inhibitory effects of Tomivosertib in acute myeloid leukemia
2021-07-12
Oncotarget published "Inhibitory effects of Tomivosertib in acute myeloid leukemia" which reported that the authors evaluated the therapeutic potential of the highly-selective MNK1/2 inhibitor Tomivosertib on AML cells. Tomivosertib was highly effective at blocking eIF4E phosphorylation on serine 209 in AML cells. Moreover, combination of Tomivosertib and Venetoclax resulted in synergistic anti-leukemic responses in AML cell lines. Mass spectrometry studies identified novel putative MNK1/2 interactors, while in parallel studies we demonstrated that MNK2 - RAPTOR - mTOR complexes are not disrupted by Tomivosertib. Overall, these Oncotarget findings demonstrate that Tomivosertib exhibits potent ...

Oncotarget: Modulating Tau Post-translational modifications and cytoskeletal network

Oncotarget: Modulating Tau Post-translational modifications and cytoskeletal network
2021-07-12
Oncotarget published "Epigallocatechin-3-gallate modulates Tau Post-translational modifications and cytoskeletal network" which reported that the chemical modulators of Tau PTMs, such as kinase inhibitors and antibody-based therapeutics, have been developed, but natural compounds, as modulators of Tau PTMs are not much explored. These authors applied biophysical and biochemical techniques like fluorescence kinetics, oligomerization analysis and transmission electron microscopy to investigate the impact of EGCG on Tau glycation in vitro. EGCG inhibited methyl glyoxal -induced Tau glycation in vitro. EGCG potently inhibited MG-induced advanced glycation endproducts formation in neuroblastoma cells as well modulated the localization ...

Oncotarget: LAPAS1 is required for S phase progression and cell proliferation

Oncotarget: LAPAS1 is required for S phase progression and cell proliferation
2021-07-12
Oncotarget published "A novel E2F1-regulated lncRNA, LAPAS1, is required for S phase progression and cell proliferation" which reported that long non-coding RNAs are major regulators of many cellular processes, including cell cycle progression and cell proliferation. Inhibition of LAPAS1 expression increases the percentage of S phase cells, and its silencing in synchronized cells delays their progression through S phase. In agreement with its suggested role in cell cycle progression, prolonged inhibition of LAPAS1 attenuates proliferation of human cancer cells. Importantly, knockdown of SPNS2 rescues the effect of LAPAS1 silencing on cell cycle ...

New electronic paper displays brilliant colours

New electronic paper displays brilliant colours
2021-07-12
Imagine sitting out in the sun, reading a digital screen as thin as paper, but seeing the same image quality as if you were indoors. Thanks to research from Chalmers University of Technology, Sweden, it could soon be a reality. A new type of reflective screen - sometimes described as 'electronic paper' - offers optimal colour display, while using ambient light to keep energy consumption to a minimum. Traditional digital screens use a backlight to illuminate the text or images displayed upon them. This is fine indoors, but we've all experienced the difficulties of viewing such screens in bright sunshine. Reflective screens, however, attempt to use the ambient light, mimicking the way our eyes ...

Protein appears to prevent tumor cells from spreading via blood vessels

2021-07-12
Researchers have identified a specialized protein that appears to help prevent tumor cells from entering the bloodstream and spreading to other parts of the body. "We have discovered that this protein, TRPM7, senses the pressure of fluid flowing in the circulation and stops the cells from spreading through the vascular system," said Kaustav Bera, a Johns Hopkins University PhD candidate in chemical and biomolecular engineering and a lead author of the study, which was done with colleagues at the University of Alberta and Universitat Pompeu Fabra. "We found that metastatic tumor cells have markedly reduced levels of this sensor protein, and that is why they ...

Monitoring proves better than active treatment for low-risk prostate cancer

2021-07-12
Men over 60 with low-risk prostate cancer could spend ten years with no active treatment, have a better sex life as a result, yet still be very unlikely to die from the disease, new research has found. The findings come from two new studies looking at 'active surveillance' of prostate cancer - when the disease is closely monitored but not treated - presented at the European Association of Urology congress, EAU21, today. The first uses data from Sweden's National Prostate Cancer Register, which has information on virtually every man diagnosed with the disease in that country since 1998 - 23,649 of whom went on active surveillance. ...

LAST 30 PRESS RELEASES:

One in four chance per year that rocket junk will enter busy airspace

Later-onset menopause linked to healthier blood vessels, lower heart disease risk

New study reveals how RNA travels between cells to control genes across generations

Women health sector leaders good for a nation’s wealth, health, innovation, ethics

‘Good’ cholesterol may be linked to heightened glaucoma risk among over 55s

GLP-1 drug shows little benefit for people with Parkinson’s disease

Generally, things really do seem better in morning, large study suggests

Juicing may harm your health in just three days, new study finds

Forest landowner motivation to control invasive species depends on land use, study shows

Coal emissions cost India millions in crop damages

$10.8 million award funds USC-led clinical trial to improve hip fracture outcomes

University Hospitals Cleveland Medical Center among most reputable academic medical centers

Emilia Morosan on team awarded Kavli Foundation grant for quantum geometry-enabled superconductivity

Unlock sales growth: Implement “buy now, pay later” to increase customer spending

Research team could redefine biomedical research

Bridging a gap in carbon removal strategies

Outside-in signaling shows a route into cancer cells

NFL wives bring signature safe swim event to New Orleans

Pickleball program boosts health and wellness for cancer survivors, Moffitt study finds

International Alzheimer’s prevention trial in young adults begins

Why your headphone battery doesn't last

Study probes how to predict complications from preeclampsia

CNIC scientists design an effective treatment strategy to prevent heart injury caused by a class of anticancer drugs

NYU’s Yann LeCun a winner of the 2025 Queen Elizabeth Prize for Engineering

New study assesses impact of agricultural research investments on biodiversity, land use

High-precision NEID spectrograph helps confirm first Gaia astrometric planet discovery

ABT-263 treatment rejuvenates aged skin and enhances wound healing

The challenge of pursuit – how saccades enable mammals to simultaneously chase prey and navigate through complex environments

Music can touch the heart, even inside the womb

Contribution of cannabis use disorder to new cases of schizophrenia has almost tripled over the past 17 years

[Press-News.org] USC researchers discover better way to identify DNA variants